Loading...
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
Hypercytokinaemic immune dysregulation in COVID-19 is known as cytokine storm syndrome. Interleukin-6 levels ≥80 pg·mL(−1) predict an increased risk of respiratory failure and death, and immunomodulatory therapy is an area of urgent investigation. https://bit.ly/3jq3uJ4
Na minha lista:
| Udgivet i: | Eur Respir J |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
European Respiratory Society
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7474149/ https://ncbi.nlm.nih.gov/pubmed/32883678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.03006-2020 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|